论文部分内容阅读
目的前瞻性地确定乳腺癌是否具有与病理及分子预后指标相关的特征性肿瘤血流量值(TBF)。材料与方法机构伦理委员会批准了该研究。获得知情同意书后,57例经
Objective To prospectively determine whether breast cancer has a characteristic tumor blood flow value (TBF) associated with pathological and molecular prognostic indicators. Materials and Methods Agency Ethics Committee approved the study. After receiving the informed consent, 57 cases of